These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8678901)

  • 1. Enhancement of ricin toxin A chain immunotoxin activity: synthesis, ionophoretic ability, and in vitro activity of monensin derivatives.
    Dosio F; Franceschi A; Ceruti M; Brusa P; Cattel L; Colombatti M
    Biochem Pharmacol; 1996 Jul; 52(1):157-66. PubMed ID: 8678901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of ricin A chain immunotoxin activity by perhexiline on established and fresh leukemic cells.
    Jaffrézou JP; Levade T; Kuhlein E; Thurneyssen O; Chiron M; Grandjean H; Carrière D; Laurent G
    Cancer Res; 1990 Sep; 50(17):5558-66. PubMed ID: 2386962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo enhancement of ricin-A chain immunotoxin activity by novel indolizine calcium channel blockers: delayed intracellular degradation linked to lipidosis induction.
    Jaffrézou JP; Levade T; Thurneyssen O; Chiron M; Bordier C; Attal M; Chatelain P; Laurent G
    Cancer Res; 1992 Mar; 52(5):1352-9. PubMed ID: 1737397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potentiation of ricin A immunotoxin by monoclonal antibody targeted monensin containing small unilamellar vesicles.
    Singh M; Griffin T; Salimi A; Micetich RG; Atwal H
    Cancer Lett; 1994 Aug; 84(1):15-21. PubMed ID: 8076359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monensin in lipid emulsion for the potentiation of ricin A chain immunotoxins.
    Griffin T; Raso V
    Cancer Res; 1991 Aug; 51(16):4316-22. PubMed ID: 1868454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of ligand effects in intracellular trafficking of ricin A chain using anti-ricin hybridomas.
    Kornfeld SB; Leonard JE; Mullen MD; Taetle R
    Cancer Res; 1991 Mar; 51(6):1689-93. PubMed ID: 1998959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of the specific cytotoxicity of a breast cancer-associated antigen immunotoxin by the carboxylic ionophore monensin.
    Griffin TW; Pagnini PG; Houston LL
    J Biol Response Mod; 1987 Oct; 6(5):537-45. PubMed ID: 3500277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of monensin derivatives and their effect on the activity of ricin A-chain immunotoxins.
    Colombatti M; Dosio F
    Methods Mol Biol; 2001; 166():55-70. PubMed ID: 11217376
    [No Abstract]   [Full Text] [Related]  

  • 9. Blocking effect of human serum but not of cerebrospinal fluid on ricin A chain immunotoxin potentiation by monensin or carrier protein-monensin conjugates.
    Candiani C; Franceschi A; Chignola R; Pasti M; Anselmi C; Benoni G; Tridente G; Colombatti M
    Cancer Res; 1992 Feb; 52(3):623-30. PubMed ID: 1732050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stability and cytotoxicity of Fab-ricin A immunotoxins prepared with water soluble long chain heterobifunctional crosslinking agents.
    Woo BH; Lee JT; Park MO; Lee KR; Han JW; Park ES; Yoo SD; Lee KC
    Arch Pharm Res; 1999 Oct; 22(5):459-63. PubMed ID: 10549572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetics of cytotoxicity induced by immunotoxins. Enhancement by lysosomotropic amines and carboxylic ionophores.
    Casellas P; Bourrie BJ; Gros P; Jansen FK
    J Biol Chem; 1984 Aug; 259(15):9359-64. PubMed ID: 6746651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensitivity of human glioma cells to cytotoxic heteroconjugates.
    Colombatti M; Bisconti M; Dell'Arciprete L; Gerosa MA; Tridente G
    Int J Cancer; 1988 Sep; 42(3):441-8. PubMed ID: 3138194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of the cytotoxic effect of anti-carcinoembryonic antigen immunotoxins by adenovirus and carboxylic ionophores.
    Griffin TW; Childs LR; FitzGerald DJ; Levin LV
    J Natl Cancer Inst; 1987 Oct; 79(4):679-85. PubMed ID: 3498854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carrier protein-monensin conjugates: enhancement of immunotoxin cytotoxicity and potential in tumor treatment.
    Colombatti M; Dell'Arciprete L; Chignola R; Tridente G
    Cancer Res; 1990 Mar; 50(5):1385-91. PubMed ID: 2302703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mediation of reduction of spontaneous and experimental pulmonary metastases by ricin A-chain immunotoxin 45-2D9-RTA with potentiation by systemic monensin in mice.
    Roth JA; Ames RS; Fry K; Lee HM; Scannon PJ
    Cancer Res; 1988 Jun; 48(12):3496-501. PubMed ID: 3259469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monensin enhances the cytotoxic effect of antitransferrin receptor immunotoxin on cultured RPE cells.
    Handa JT; Houston LL; Jaffe GJ
    Curr Eye Res; 1993 Jan; 12(1):45-53. PubMed ID: 8436010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IgE-immunotoxins. II. IgE-ricin A-chain.
    Boltansky H; Slater J; Youle R; Isersky C; Kaliner M
    Immunopharmacology; 1987 Sep; 14(1):47-62. PubMed ID: 3500150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potent cytotoxicity of an antihuman transferrin receptor-ricin A-chain immunotoxin on human glioma cells in vitro.
    Recht LD; Griffin TW; Raso V; Salimi AR
    Cancer Res; 1990 Oct; 50(20):6696-700. PubMed ID: 2208135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclosporin A and cyclosporin SDZ PSC 833 enhance anti-CD5 ricin A-chain immunotoxins in human leukemic T cells.
    Jaffrézou JP; Sikic BI; Laurent G
    Blood; 1994 Jan; 83(2):482-9. PubMed ID: 7506953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carboxylic ionophores enhance the cytotoxic potency of ligand- and antibody-delivered ricin A chain.
    Raso V; Lawrence J
    J Exp Med; 1984 Oct; 160(4):1234-40. PubMed ID: 6090575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.